Okupe Oluyemi 4
4 · Hims & Hers Health, Inc. · Filed Mar 13, 2026
Research Summary
AI-generated summary of this filing
Hims & Hers (HIMS) CFO Okupe Oluyemi Receives 300,978 RSUs
What Happened
- Okupe Oluyemi, Chief Financial Officer of Hims & Hers Health, Inc. (HIMS), was granted 300,978 restricted stock units (RSUs) on 2026-03-11. The award was granted at $0.00 per unit (no cash exchanged) and is reported as a derivative award that can convert to ordinary shares upon vesting.
Key Details
- Transaction date: 2026-03-11; Form 4 filed: 2026-03-13 (reporting period 2026-03-11).
- Grant: 300,978 RSUs; price reported: $0.00; reported value: $0 (derivative award).
- Shares owned after transaction: Not disclosed in the filing.
- Footnote F1: Each RSU represents a contingent right to receive one share of Class A common stock upon vesting.
- Footnote F2: RSUs vest based on service over 4 years in substantially equal quarterly installments on Mar 15, Jun 15, Sep 15 and Dec 15, with the first vesting date on June 15, 2026.
- Transaction code: A (award/grant). Filing does not indicate lateness.
Context
- This is a compensation award, not an open-market purchase or sale — it does not reflect an immediate cash investment or liquidation by the insider. RSUs convert to actual shares only as they vest according to the schedule above. For retail investors, such grants indicate company compensation practice and potential future dilution as units vest and convert to shares.
Insider Transaction Report
Form 4
Okupe Oluyemi
Chief Financial Officer
Transactions
- Award
Restricted Stock Unit
[F1][F2]2026-03-11+300,978→ 300,978 total→ Class A Common Stock (300,978 underlying)
Footnotes (2)
- [F1]The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
- [F2]The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2026.
Signature
/s/ Kimberly Mather, Attorney-in-Fact for Oluyemi Okupe|2026-03-13